Acumen Pharmaceuticals, Inc. (ABOS) NASDAQ
2.37
-0.14(-5.58%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.37
-0.14(-5.58%)
Currency In USD
| Market Cap | 127.79M |
| Enterprise Value | 105.11M |
| P/E Ratio | -1.32 |
| PEG Ratio | 1.51 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.71 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.96 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.85 |
| Return On Equity | -1.23 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -116.93M |
| Net Income | -121.34M |
| Diluted EPS | -2 |
| Total Cash | 128.4M |
| Total Cash/Share | 2.03 |
| Total Debt | 14.12M |
| Total Debt/Equity | 0.16 |
| Current Ratio | 4.55 |
| Book Value Per Share | 1.38 |
| 52-Week Change | 137 |
| 52-Week High | 3.6 |
| 52-Week Low | 1 |
| Moving Average 50 Days | 2.52 |
| Moving Average 200 Days | 2.18 |
| Average Volume | 536,109 |
| Shares Outstanding | 60.57M |
| % Held by Institutions | 75.96 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |